留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

冠状动脉扩张是胎儿生长受限预后不良的独立危险因素

黄丹萍 王红英 陈韵羽 刘金蓉 戴常平 杜妍妍 王娜

黄丹萍, 王红英, 陈韵羽, 刘金蓉, 戴常平, 杜妍妍, 王娜. 冠状动脉扩张是胎儿生长受限预后不良的独立危险因素[J]. 分子影像学杂志, 2021, 44(2): 281-285. doi: 10.12122/j.issn.1674-4500.2021.02.13
引用本文: 黄丹萍, 王红英, 陈韵羽, 刘金蓉, 戴常平, 杜妍妍, 王娜. 冠状动脉扩张是胎儿生长受限预后不良的独立危险因素[J]. 分子影像学杂志, 2021, 44(2): 281-285. doi: 10.12122/j.issn.1674-4500.2021.02.13
Danping HUANG, Hongying WANG, Yunyu CHEN, Jinrong LIU, Changping DAI, Yanyan DU, Na WANG. Value of coronary artery dilatation in prognosis fetal growth restriction[J]. Journal of Molecular Imaging, 2021, 44(2): 281-285. doi: 10.12122/j.issn.1674-4500.2021.02.13
Citation: Danping HUANG, Hongying WANG, Yunyu CHEN, Jinrong LIU, Changping DAI, Yanyan DU, Na WANG. Value of coronary artery dilatation in prognosis fetal growth restriction[J]. Journal of Molecular Imaging, 2021, 44(2): 281-285. doi: 10.12122/j.issn.1674-4500.2021.02.13

冠状动脉扩张是胎儿生长受限预后不良的独立危险因素

doi: 10.12122/j.issn.1674-4500.2021.02.13
基金项目: 

广东省医学科学技术研究基金 A2020403

详细信息
    作者简介:

    黄丹萍,副主任医师,E-mail: 512136389@qq.com

    通讯作者:

    王娜,副主任医师,E-mail: 423352651@qq.com

Value of coronary artery dilatation in prognosis fetal growth restriction

  • 摘要: 目的探讨冠状动脉扩张在胎儿生长受限(FGR)中的预后评估价值。方法收集2019年1月~2020年12月我院超声诊断并出生后证实FGR胎儿73例,超声观察冠状动脉(CA)扩张、脐动脉、大脑中动脉(MCA)、静脉导管的血流频谱特征。根据胎儿妊娠结局分为预后良好组和预后不良组,比较胎儿的一般情况及胎儿不同血流异常情况,以超声变量特征建立Logistic回归模型,并绘制受试者工作特征曲线,评价Logistic回归模型对胎儿不良预后的预测价值。结果FGR胎儿预后不良组27例,预后良好组46例,在脐动脉异常、静脉导管异常、CA扩张组比较差异有统计学意义(P < 0.05),MCA异常组未见明显统计学意义(P>0.05)。Logistic回归分析显示CA扩张、脐动脉异常、静脉导管异常组OR值分别为9.715、4.956、11.291,为胎儿不良预后的独立的危险因素。以CA扩张、脐动脉异常、静脉导管异常3组变量建立的Logistic回归模型预测FGR胎儿不良预后(回归值>0.356)的曲线下面积为0.874,敏感度为81.48%,特异性为91.30%。结论冠状动脉扩张是FGR预后不良的独立的危险因素。以CA扩张、脐动脉异常、静脉导管异常3个血流异常变量建立的Logistic回归模型能够有效预测FGR不良预后。

     

  • 图  1  左室流出道切面彩色多普勒显示右冠状动脉扩张

    Figure  1.  This view of the left ventricular outflow tract shows color Doppler imaging of the right coronary artery dilatation.

    图  2  频谱多普勒显示冠状动脉舒张期血流增高

    Figure  2.  PW showes increased coronary diastolic blood flow.

    图  3  UA异常、DV异常、CA扩张预测FGR胎儿不良预后的ROC

    Figure  3.  ROC of abnormal UA, abnormal DV, and dilated CApredicting adverse prognosis in FGR.

    表  1  FGR胎儿不良结局单因素分析

    Table  1.   Univariate analysis of fetal adverse outcomes in FGR[n(%)]

    因素 预后良好组(n=46) 预后不良组(n=27) χ2 P
    年龄(岁) 28.50(21~40) 30.00(20~44) 508.50 0.197
    首诊孕周(周) 35.50(25.1~39.0) 30.6(23.4~39.2) 325.00 0.001
    出生或胎儿死亡孕周(周) 36.60(28.20~39.60) 31.50(24.10~40.10) 315.00 0.001
    出生体质量(g) 1950(880~2480) 1050(214~2460) 264.00 0.001
    Apgar 1 min 9(8~10) 0(0~9) 88.50 0.001
    Apgar 5 min 10(8~10) 0(0~9) 58.00 0.001
    Apgar 10 min 10(9~10) 0(0~10) 91.00 0.001
    MCA异常 27(0.59) 17(0.63) 0.13 0.719
    UA异常 14(0.30) 20(0.74) 13.02 0.001
    DV异常 2(0.04) 12(0.44) 17.65 0.001
    CA扩张 11(0.24) 22(0.82) 22.76 0.001
    MCA: 大脑中动脉; UA: 脐动脉; DV: 静脉导管; CA: 冠状动脉
    下载: 导出CSV

    表  2  FGR胎儿不良结局影响因素的多因素Logistic回归分析结果

    Table  2.   Multivariate Logistic regression analysis of factors affecting fetal adverse outcomes in FGR

    项目 B S.E. Wald值 OR值(95%CI) P
    UA异常 1.513 0.68 4.956 4.539(1.198~17.193) 0.026
    DV异常 2.424 0.942 6.621 11.291(1.782~71.543) 0.01
    CA扩张 2.274 0.691 10.827 9.715(2.508~37.636) 0.001
    常数项 -3.017 0.702 18.492 - 0.001
    下载: 导出CSV
  • [1] 中华医学会围产医学分会胎儿医学学组, 中华医学会妇产科学分会产科学组. 胎儿生长受限专家共识(2019版[) J]. 中华围产医学杂志, 2019, 22(6): 361-80. doi: 10.3760/cma.j.issn.1007-9408.2019.06.001
    [2] ACOG practice bulletin no. 204 summary: fetal growth restriction [J]. Obstet Gynecol, 2019, 133(2): 390-2. doi: 10.1097/AOG.0000000000003071
    [3] Gynecologists ACOOA. ACOG Practice bulletin no. 134: fetal growth restriction[J]. Obstet Gynecol, 2013, 121(5): 1122-33. doi: 10.1097/01.AOG.0000429658.85846.f9
    [4] Lausman A, Kingdom J. Maternal fetal medicine committee. Intrauterine growth restriction: screening, diagnosis, and management[J]. J Obstet Gynaecol Can, 2013, 35(8): 741-8. doi: 10.1016/S1701-2163(15)30865-3
    [5] Briana DD, Malamitsi-Puchner A. Coronary intimal thickening begins in fetuses: proof of concept for the "fetal origins of adult disease"hypothesis[J]. Angiology, 2020, 71(1): 89. doi: 10.1177/0003319719857384
    [6] Guerri-Guttenberg R, Castilla R, Cao G, et al. Coronary intimal thickening begins in fetuses and progresses in pediatric population and adolescents to atherosclerosis[J]. Angiology, 2020, 71(1): 62-9. doi: 10.1177/0003319719849784
    [7] Riise HKR, Sulo G, Tell GS, et al. Incident coronary heart disease after preeclampsia: role of reduced fetal growth, preterm delivery, and parity[J]. JAm HeartAssoc, 2017, 6(3): e004158. http://europepmc.org/articles/PMC5523993/
    [8] Baschat AA. Fetal responses to placental insufficiency: an update[J]. BJOG, 2004, 111(10): 1031-41. doi: 10.1111/j.1471-0528.2004.00273.x
    [9] Crispi F, Hernandez-Andrade E, Pelsers MM, et al. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses[J]. Am J Obstet Gynecol, 2008, 199(3): 254. e1-8. http://www.ncbi.nlm.nih.gov/pubmed/18771973
    [10] Garcia-Canadilla P, de Vries T, Gonzalez-Tendero A, et al. Structural coronary artery remodelling in the rabbit fetus as a result of intrauterine growth restriction[J]. PLoS One, 2019, 14(6): e0218192. doi: 10.1371/journal.pone.0218192
    [11] Bui YK, Howley LW, Ambrose SE, et al. Prominent coronary artery flow with normal coronary artery anatomy is a rare but ominous harbinger of poor outcome in the fetus[J]. J Matern Fetal Neonatal Med, 2016, 29(10): 1536-40. doi: 10.3109/14767058.2015.1057492
    [12] Rizzo G, Capponi A, Pietrolucci ME, et al. The significance of visualising coronary blood flow in early onset severe growth restricted fetuses with reverse flow in the ductus venosus[J]. J Matern Fetal Neonatal Med, 2009, 22(7): 547-51. doi: 10.1080/14767050902801777
    [13] 刘建君, 郭燕丽, 薛雅方, 等. 产前超声诊断胎儿冠状动脉代偿性扩张[J]. 中国医学影像技术, 2020, 36(7): 1057-60. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX202007030.htm
    [14] Wang Y, Wei J, Liu GL, et al. Effect of regular third-trimester ultrasound examination on antenatal detection and perinatal outcomes of small for gestational age infants[J]. J Int Med Res, 2021, 49(2): 300060521989204. http://www.researchgate.net/publication/349059536_Effect_of_regular_third-trimester_ultrasound_examination_on_antenatal_detection_and_perinatal_outcomes_of_small_for_gestational_age_infants
    [15] Kanagawa T, Ishii K, Yamamoto R, et al. Fetal outcomes associated with the sequence of Doppler deterioration in severely growthrestricted fetuses[J]. J Ultrasound Med, 2021. DOI: 10.1002/ jum.15614.
    [16] Afonso S, Bandow GT, Rowe GG. Indomethacin and the prostaglandin hypothesis of coronary blood flow regulation[J]. J Physiol, 1974, 241(2): 299-308. doi: 10.1113/jphysiol.1974.sp010657
    [17] Jonker SS, Giraud GD, Chang EI, et al. Coronary vascular growth matches IGF-1-stimulated cardiac growth in fetal sheep[J]. FASEB J, 2020, 34(8): 10041-55. doi: 10.1096/fj.202000215R
    [18] Davis L, Musso J, Soman D, et al. Role of adenosine signaling in coordinating cardiomyocyte function and coronary vascular growth in chronic fetal Anemia[J]. Am J Physiol Regul Integr Comp Physiol, 2018, 315(3): R500-R508. doi: 10.1152/ajpregu.00319.2017
    [19] Cohn HE, Sacks EJ, Heymann MA, et al. Cardiovascular responses to hypoxemia and acidemia in fetal lambs[J]. Am J Obstet Gynecol, 1974, 120(6): 817-24. doi: 10.1016/0002-9378(74)90587-0
    [20] Baschat AA, Gembruch U. Evaluation of the fetal coronary circulation[J]. Ultrasound Obstet Gynecol, 2002, 20(4): 405-12. doi: 10.1046/j.1469-0705.2002.00798.x
    [21] Chaoui R. Coronary arteries in fetal life: physiology, malformations and the "heart-sparing effect"[J]. Acta Paediatr Suppl, 2004, 93 (446): 6-12. http://europepmc.org/abstract/MED/15702664
    [22] Baschat AA, Gembruch U, Reiss I, et al. Demonstration of fetal coronary blood flow by Doppler ultrasound in relation to arterial and venous flow velocity waveforms and perinatal outcome-the 'heartsparing effect'[J]. Ultrasound Obstet Gynecol, 1997, 9(3): 162-72. doi: 10.1046/j.1469-0705.1997.09030162.x
    [23] Fujimori K, Murata Y, Quilligan EJ, et al. Distribution of oxygenated blood flow at three different routes of extracorporeal membrane oxygenation in exteriorized fetal lambs[J]. J Obstet Gynaecol Res, 2001, 27(2): 103-9. doi: 10.1111/j.1447-0756.2001.tb01229.x
    [24] Reller MD, Morton MJ, Giraud GD, et al. Maximal myocardial blood flow is enhanced by chronic hypoxemia in late gestation fetal sheep[J]. Am J Physiol, 1992, 263(4 Pt 2): H1327-9. http://www.ncbi.nlm.nih.gov/pubmed/1415781
    [25] Alfirevic Z, Stampalija T, Dowswell T. Fetal and umbilical Doppler ultrasound in high-risk pregnancies[J]. Cochrane Database Syst Rev, 2017, 6: CD007529. http://pubmedcentralcanada.ca/pmcc/articles/PMC4167858/
    [26] Vergani P, Roncaglia N, Ghidini A, et al. Can adverse neonatal outcome be predicted in late preterm or term fetal growth restriction? [J]. Ultrasound Obstet Gynecol, 2010, 36(2): 166-70. doi: 10.1002/uog.7583
    [27] Wolf H, Stampalija T, Lees CC, et al. Fetal cerebral blood flow redistribution: an analysis of Doppler reference charts and the association of different thresholds with adverse perinatal outcome [J]. Ultrasound Obstet Gynecol, 2021. DOI: 10.1002/uog.23615.
    [28] Lees CC, Marlow N, van Wassenaer- Leemhuis A, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial[J]. Lancet, 2015, 385(9983): 2162-72. doi: 10.1016/S0140-6736(14)62049-3
    [29] McCowan LM, Harding JE, Roberts AB, et al. A pilot randomized controlled trial of two regimens of fetal surveillance for small-forgestational-age fetuses with normal results of umbilical artery Doppler velocimetry[J]. Am J Obstet Gynecol, 2000, 182(1 pt 1): 81-6. http://europepmc.org/abstract/MED/10649160
    [30] Yagel S, Kivilevitch Z, Cohen SM, et al. The fetal venous system, Part Ⅱ: ultrasound evaluation of the fetus with congenital venous system malformation or developing circulatory compromise[J]. Ultrasound Obstet Gynecol, 2010, 36(1): 93-111. doi: 10.1002/uog.7622
    [31] Magann EF, Chauhan SP, Hitt WC, et al. Borderline or marginal amniotic fluid index and peripartum outcomes[J]. J Ultrasound Med, 2011, 30(4): 523-8. doi: 10.7863/jum.2011.30.4.523
    [32] Baschat AA, Muench MV, Gembruch U. Coronary artery blood flow velocities in various fetal conditions[J]. Ultrasound Obstet Gynecol, 2003, 21(5): 426-9. doi: 10.1002/uog.82
  • 加载中
图(3) / 表(2)
计量
  • 文章访问数:  611
  • HTML全文浏览量:  234
  • PDF下载量:  4
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-03-03
  • 刊出日期:  2021-03-20

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日